Cost-effectiveness analysis of 3D versus 2D transesophageal echocardiography for the evaluation of patients with primary mitral regurgitation with indication of surgical treatment
European heart journal. Cardiovascular imaging
; 21(supl. 1): 73-73, Jan., 2020. graf.
Article
em En
| SES-SP, SESSP-IDPCPROD, SES-SP
| ID: biblio-1052842
Biblioteca responsável:
BR79.1
ABSTRACT
OBJECTIVES:
To perform the cost-effectiveness analysis of three-dimensional transesophageal echocardiography (3DTEE) in comparison to two-dimensional transesophageal echocardiography (2DTEE) for the anatomic-functional evaluation and surgical planning of severe primary mitral regurgitation.METHODS:
a complete economic study was based on a systematic review of 3DTEE and 2DTEE accuracy and private health system costs of two different surgicalinterventions:
mitral valve plasty and mitral valve replacement. The prevalence of common postoperative complications was also predicted for elective procedures atrial fibrillation (8.6%); acute myocardial infarction (1.4%); thrombosis (3.5%); bleeding (1.5%); endocarditis (6.3%). The decision tree method was adopted as a data analysis model. The Bayes" theorem was used based on sensitivity and specificity measurements. The costs, considering literature and professional tables, were 3DTEE = US$ 349; 2DTEE = US$ 204; diagnostic evaluation = US$ 597; surgical procedure = US$ 3,643; surgical treatment = US$ 374.RESULTS:
The deterministic analysis of the diagnostic test shows that 3DTEE (non-dominated) is superior to 2DTEE (absolutely dominated). The 3DTEE presents a cost reduction of US$ 1,147 and incremental effectiveness (true identification) of 22% when compared to 2DTEE. The multivariate probabilistic sensitivity analysis showed that after 100,000 iterations, the diagnosis based on the 3DTEE becomes the first choice regardless of the willingness to pay threshold.CONCLUSIONS:
3DTEE was cost-effective compared to 2DTEE. Thus, 3DTEE is a potential device to promote health compared to 2DTEE for surgical planning of severe primary mitral regurgitation. (AU)
Buscar no Google
Coleções:
06-national
/
BR
Contexto em Saúde:
1_ASSA2030
Base de dados:
SES-SP
/
SESSP-IDPCPROD
Assunto principal:
Análise Custo-Benefício
/
Ecocardiografia Transesofagiana
/
Insuficiência da Valva Mitral
Tipo de estudo:
Health_economic_evaluation
/
Prognostic_studies
/
Risk_factors_studies
Aspecto:
Patient_preference
Idioma:
En
Revista:
European heart journal. Cardiovascular imaging
Ano de publicação:
2020
Tipo de documento:
Article